Protein Kinase Activity of Phosphoinositide 3-Kinase Regulates Cytokine-Dependent Cell Survival

PLoS Biology

Volumn 11, Issue 3, 2013, Pages

  Thomas, Daniel ^a   Powell, Jason A ^a   Green, Benjamin D ^b   Barry, Emma F ^a   Ma, Yuefang ^a   Woodcock, Joanna ^a   Fitter, Stephen ^c   Zannettino, Andrew C W ^c   Pitson, Stuart M ^a   Hughes, Timothy P ^c   Lopez, Angel F ^a   Shepherd, Peter R ^d   Wei, Andrew H ^b,e   Ekert, Paul G ^f   Guthridge, Mark A ^a,b  

^a CENTRE FOR CANCER BIOLOGY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e ALFRED HOSPITAL   (Australia)

^f WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PLECKSTRIN; PROTEIN P110; PROTEIN P110 ALPHA; SERINE; UNCLASSIFIED DRUG; WORTMANNIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TREATMENT RESPONSE;

CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; CLASS I PHOSPHATIDYLINOSITOL 3-KINASES; CYTOKINES; HUMANS; LEUKEMIA, MYELOID, ACUTE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84875456580     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001515     Document Type: Article

References (33)

1. Cantley LC, (2002) The phosphoinositide 3-kinase pathway. Science 296: 1655-1657.
2. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, et al. (1994) PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13: 522-533.
3. Hunter T, (1995) When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83: 1-4.
4. Foukas LC, Shepherd PR, (2004) Phosphoinositide 3-kinase: the protein kinase that time forgot. Biochem Soc Trans 32: 330-331.
5. Guthridge MA, Stomski FC, Barry EF, Winnall W, Woodcock JM, et al. (2000) Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival. Mol Cell 6: 99-108.
6. Guthridge MA, Barry EF, Felquer FA, McClure BJ, Stomski FC, et al. (2004) The phosphoserine-585-dependent pathway of the GM-CSF/IL-3/IL-5 receptors mediates hematopoietic cell survival through activation of NF-kappaB and induction of bcl-2. Blood 103: 820-827.
7. Guthridge MA, Powell JA, Barry EF, Stomski FC, McClure BJ, et al. (2006) Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch. EMBO J 25: 479-489.
8. Lonic A, Barry EF, Quach C, Kobe B, Saunders N, et al. (2008) Fibroblast growth factor receptor 2 phosphorylation on serine 779 couples to 14-3-3 and regulates cell survival and proliferation. Mol Cell Biol 28: 3372-3385.
9. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, et al. (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19: 7203-7215.
10. Powell JA, Thomas D, Barry EF, Kok CH, McClure BJ, et al. (2009) Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML. Blood 114: 4859-4870.
11. Guthridge MA, Stomski FC, Thomas D, Woodcock JM, Bagley CJ, et al. (1998) Mechanism of activation of the GM-CSF, IL-3 and IL-5 family of receptors. Stem Cells 16: 301-313.
12. Naga Prasad SV, Jayatilleke A, Madamanchi A, Rockman HA, (2005) Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat Cell Biol 7: 785-796.
13. Kim JE, Shepherd PR, Chaussade C, (2009) Investigating the role of class-IA PI 3-kinase isoforms in adipocyte differentiation. Biochem Biophys Res Commun 379: 830-834.
14. Foukas LC, Beeton CA, Jensen J, Phillips WA, Shepherd PR, (2004) Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. Mol Cell Biol 24: 966-975.
15. Czupalla C, Culo M, Muller EC, Brock C, Reusch HP, et al. (2003) Identification and characterization of the autophosphorylation sites of phosphoinositide 3-kinase isoforms beta and gamma. J Biol Chem 278: 11536-11545.
16. Vanhaesebroeck B, Higashi K, Raven C, Welham M, Anderson S, et al. (1999) Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo. EMBO J 18: 1292-1302.
17. Bondev A, Rubio I, Wetzker R, (1999) Differential regulation of lipid and protein kinase activities of phosphoinositide 3-kinase gamma in vitro. BiolChem 380: 1337-1340.
18. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL, (1994) The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem 269: 20648-20652.
19. Tanti JF, Gremeaux T, Van OE, Le Marchand-Brustel Y, (1994) Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J 304: 17-21.
20. Rondinone CM, Carvalho E, Rahn T, Manganiello VC, Degerman E, et al. (2000) Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor. J Biol Chem 275: 10093-10098.
21. Foukas LC, Shepherd PR, (2004) eIF4E binding protein 1 and H-Ras are novel substrates for the protein kinase activity of class-I phosphoinositide 3-kinase. Biochem Biophys Res Commun 319: 541-549.
22. Pawson T, (2004) Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116: 191-203.
23. Schlessinger J, (2000) Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
24. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R, et al. (1998) Bifurcation of lipid and protein kinase signals of PI3Kgamma to the protein kinases PKB and MAPK. Science 282: 293-296.
25. Uddin S, Majchrzak B, Wang PC, Modi S, Khan MK, et al. (2000) Interferon-dependent activation of the serine kinase PI 3′-kinase requires engagement of the IRS pathway but not the Stat pathway. Biochem Biophys Res Commun 270: 158-162.
26. Curnock AP, Logan MK, Ward SG, (2002) Chemokine signaling: pivoting around multiple phosphoinositide 3-kinases. Immunology 105: 125-136.
27. Jiang X, Chen S, Asara JM, Balk SP, (2010) Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits. J Biol Chem 285: 14980-14989.
28. Perugini M, Brown AL, Salerno DG, Booker GW, Stojkoski C, et al. (2010) Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit. Blood 115: 3346-3353.
29. Neal CL, Xu J, Li P, Mori S, Yang J, et al. (2012) Overexpression of 14-3-3zeta in cancer cells activates PI3K via binding the p85 regulatory subunit. Oncogene 31: 897-906.
30. Muller CI, Miller CW, Hofmann WK, Gross ME, Walsh CS, et al. (2007) Rare mutations of the PIK3CA gene in malignancies of the hematopoietic system as well as endometrium, ovary, prostate and osteosarcomas, and discovery of a PIK3CA pseudogene. Leuk Res 31: 27-32.
31. Sujobert P, Bardet V, Cornillet-Lefebvre P, Hayflick JS, Prie N, et al. (2005) Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. Blood 106: 1063-1066.
32. Ekert PG, Read SH, Silke J, Marsden VS, Kaufmann H, et al. (2004) Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 165: 835-842.
33. Gu H, Maeda H, Moon JJ, Lord JD, Yoakim M, et al. (2000) New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. MolCell Biol 20: 7109-7120.